Dabigatran in Clinical Practice for Atrial Fibrillation With Special Reference to Activated Partial Thromboplastin Time

DOI Web Site PubMed 被引用文献15件 参考文献3件

この論文をさがす

抄録

Background: The distribution of activated partial thromboplastin time (APTT) in nonvalvular atrial fibrillation (NVAF) patients under dabigatran therapy remains to be clarified. Methods and Results: The study population was 196 NVAF patients who were treated with dabigatran in 2011 (126 with 220mg/day). The APTT values showed a wide distribution among the patients, especially in those with a reduced dose, who seemed to show a high value even in patients without contraindications. Conclusions: We found a wide distribution of APTT in NVAF patients under dabigatran treatment. High APTT might help screen for bleeding risks among patients under dabigatran, but requires future investigation. (Circ J 2012; 76: 755-757)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 76 (3), 755-757, 2012

    一般社団法人 日本循環器学会

被引用文献 (15)*注記

もっと見る

参考文献 (3)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ